Quantitative Proteomics Reveals Molecular Network Driving Stromal Cell Differentiation: Implications for Corneal Wound Healing.
LCMS
SLIT-ROBO signaling
TGF-β
actin cytoskeleton
calcium signaling
cornea
fibroblasts
integrin signaling
keratocytes
myofibroblasts
quantitative proteomics
wound healing
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Feb 2022
25 Feb 2022
Historique:
received:
18
12
2021
revised:
12
02
2022
accepted:
13
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
9
4
2022
Statut:
epublish
Résumé
The differentiation of keratocytes to fibroblasts and myofibroblasts is an essential requisite during corneal wound closure. The aim of this study is to uncover factors involved in differentiation-dependent alteration in the protein profile of human corneal stromal cells using quantitative proteomics. Human corneal fibroblasts were cultured and differentiated into keratocytes in serum-free media and myofibroblasts through treatment with TGF-β. The protein cell lysates from the donors were tryptic and were digested and labeled using a 3-plex iTRAQ kit. The labeled peptides were subjected to LCMS analysis. Biological functional analysis revealed a set of crucial proteins involved in the differentiation of human corneal stromal cells which were found to be significantly enriched. The selected proteins were further validated by immunohistochemistry. Quantitative proteomics identified key differentially expressed proteins which are involved in cellular signaling pathways. Proteins involved in integrin signaling (Ras-RAP1b, TLN and FN) and SLIT-ROBO pathways (PFN1, CAPR1, PSMA5) as well as extracellular matrix proteins (SERPINH1, SPARC, ITGβ1, CRTAP) showed enhanced expression in corneal fibroblasts and myofibroblasts compared to keratocytes, indicating their possible role in wound healing. Corneal stromal cell differentiation is associated with the activation of diverse molecular pathways critical for the repair of fibroblasts and myofibroblasts. Identified proteins such as profilin 1 and talin could play a tentative role in corneal healing and serve as a potential target to treat corneal fibrosis.
Identifiants
pubmed: 35269714
pii: ijms23052572
doi: 10.3390/ijms23052572
pmc: PMC8910342
pii:
doi:
Substances chimiques
PFN1 protein, human
0
Profilins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Invest Ophthalmol Vis Sci. 1998 Oct;39(11):2018-32
pubmed: 9761280
J Tissue Eng Regen Med. 2011 Aug;5(8):e228-38
pubmed: 21604386
Mol Biol Cell. 2007 Jul;18(7):2716-27
pubmed: 17507651
Reproduction. 2010 Apr;139(4):697-704
pubmed: 20100881
Semin Cell Dev Biol. 2017 Feb;62:142-151
pubmed: 27838364
Mol Cell Proteomics. 2004 May;3(5):466-77
pubmed: 14766930
Arch Ophthalmol. 1998 Nov;116(11):1470-4
pubmed: 9823348
J Biol Chem. 2001 Nov 23;276(47):44173-8
pubmed: 11555658
Int J Mol Sci. 2021 Jun 25;22(13):
pubmed: 34202091
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4219-23
pubmed: 8633044
Br J Ophthalmol. 2016 Jan;100(1):28-33
pubmed: 26405102
Cornea. 1996 Sep;15(5):505-16
pubmed: 8862928
Biomaterials. 2006 Sep;27(25):4443-52
pubmed: 16678257
Development. 2016 Sep 1;143(17):3037-44
pubmed: 27578174
Exp Eye Res. 2004 Nov;79(5):705-12
pubmed: 15500828
Exp Eye Res. 2003 Jan;76(1):71-87
pubmed: 12589777
Biochim Biophys Acta. 2014 Feb;1838(2):579-88
pubmed: 23891718
Invest Ophthalmol Vis Sci. 2015 Feb 03;56(2):738-50
pubmed: 25648341
Mol Cell Proteomics. 2004 Jul;3(7):660-74
pubmed: 15054125
Invest Ophthalmol Vis Sci. 1983 May;24(5):543-56
pubmed: 6841000
J Cell Biol. 1993 Jun;121(6):1433-44
pubmed: 8509459
Tohoku J Exp Med. 2013;230(2):67-73
pubmed: 23774326
Invest Ophthalmol Vis Sci. 2006 May;47(5):1886-94
pubmed: 16638995
Invest Ophthalmol Vis Sci. 2012 Mar 01;53(3):1077-86
pubmed: 22247479
Nat Protoc. 2013 Aug;8(8):1551-66
pubmed: 23868073
Invest Ophthalmol Vis Sci. 1995 Apr;36(5):809-19
pubmed: 7706029
Dev Biol. 1986 Aug;116(2):267-77
pubmed: 2942429
J Cell Sci. 2009 Jun 15;122(Pt 12):1947-53
pubmed: 19494122
Cell. 2000 Jun 23;101(7):703-15
pubmed: 10892742
J Refract Surg. 2015 Sep;31(9):638-9
pubmed: 26352571
Am J Ophthalmol. 1997 Sep;124(3):303-11
pubmed: 9439356
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2603-8
pubmed: 12147591
PLoS One. 2014 Jan 21;9(1):e86260
pubmed: 24465995
Arch Ophthalmol. 2001 Jun;119(6):889-96
pubmed: 11405841
Vet Ophthalmol. 2010 Jan;13(1):37-42
pubmed: 20149174
J Periodontal Res. 2013 Jun;48(3):357-66
pubmed: 23058002
Exp Eye Res. 2016 Jan;142:110-8
pubmed: 26675407
Bioinformatics. 2017 Nov 01;33(21):3461-3467
pubmed: 29077811
Vet Ophthalmol. 2009 Nov-Dec;12 Suppl 1:25-7
pubmed: 19891648
J Cell Biol. 1993 Jul;122(1):103-11
pubmed: 8314838
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3083-8
pubmed: 17591877
Prog Retin Eye Res. 2015 Nov;49:17-45
pubmed: 26197361
Cell Res. 2012 Nov;22(11):1512-4
pubmed: 22777425
Exp Cell Res. 2012 Apr 1;318(6):741-52
pubmed: 22233682
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):870-7
pubmed: 8125750
Mol Biol Cell. 2006 May;17(5):2346-55
pubmed: 16525016
Eye (Lond). 2005 May;19(5):584-8
pubmed: 15332107
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4121-6
pubmed: 24591594
Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1658-63
pubmed: 10393032
Exp Eye Res. 2020 Mar;192:107936
pubmed: 32001250
N Engl J Med. 2006 Dec 28;355(26):2757-64
pubmed: 17192541
Physiol Rev. 2002 Apr;82(2):331-71
pubmed: 11917092